Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Children : Paediatric use should only occur under specialist supervision, typically in diagnosed deficiency states or specific metabolic disorders
Cognitive function following 12-weeks exenatide versus placebo The results from the trial describing the ability of exenatide to significantly lower ICP at 12 weeks have been previously published [19]
Form: Subcutaneous injection Strength: 0.25 mg dose pen 0.5 mg dose pen 1 mg dose pen 1.7 mg dose pen 2.4 mg dose pen 3
Professional Compounding Centers of America
US$ 22.00
US$ 27.67
US$ 20.26
US$ 20.96
US$ 21.20
US$ 27.88
US$ 26.39
US$ 26.29
